Seres therapeutics reports inducement grants under nasdaq listing rule 5635(c)(4)

Cambridge, mass, june 07, 2024 (globe newswire) -- seres therapeutics, inc. (nasdaq: mcrb) (“seres” or the “company”), a leading microbiome therapeutics company, today announced that on june 5, 2024, the compensation and talent committee of seres' board of directors granted inducement equity grants covering an aggregate of 6,188 shares of its common stock to one new employee, consisting of stock options to purchase 4,125 shares of common stock and restricted stock units (“rsus”) covering 2,063 shares of its common stock.
MCRB Ratings Summary
MCRB Quant Ranking